Only a quarter of patients with a hip fracture are discharged from hospital on a bisphosphonate, a registry report reveals.
Figures from the first annual report from Australian and New Zealand Hip Fracture Registry showed that only 22% of patients discharged from an Australian hospital were prescribed a bisphosphonate, compared to 15% on admission.
And 40% of hip fracture patients left hospital in New Zealand on a bisphosphonate, compared to 8% on admission.
“The lack of measures to prevent a further fracture is reflected in the facility level audit, which shows low proportions of facilities with falls clinics, osteoporosis clinics and fracture liaison services,” noted the report which involved data from 25 hospitals.
You can read the full report here.